amiodarone has been researched along with Dyspnea in 29 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) may develop long after amiodarone withdrawal." | 9.17 | Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal. ( Hachiya, H; Hirao, K; Isobe, M; Kawabata, M; Nakamura, T; Sasano, T; Sugiyama, K; Tanaka, Y; Yagishita, A, 2013) |
| "A 70-year-old woman suffering from atrial fibrillation was treated with amiodarone, but developed acute respiratory failure necessitating mechanical ventilation for four weeks." | 7.69 | [Respiratory insufficiency due to pulmonary toxicity of amiodarone]. ( Jukema, GJ; Kerkhof, SC; Strack van Schijndel, RJ; ter Maaten, JC, 1995) |
| "A case of amiodarone pulmonary toxicity (APT) occurring within days of the start of therapy and presenting with hemoptysis is reported." | 7.69 | Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. ( Goldstein, I; Heller, I; Isakov, A; Segev, D; Topilsky, M, 1997) |
| "Amiodarone was used to treat cardiac arrhythmias that had been refractory to conventional medical therapy." | 7.66 | Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. ( Gorham, JP; Graham, EL; Greene, HL; Gross, BW; Kudenchuk, PJ; Sears, GK; Trobaugh, GB; Werner, JA, 1983) |
| "Amiodarone is a class III antiarrhythmic medication used extensively to treat ventricular arrhythmias." | 5.33 | The importance of amiodarone pulmonary toxicity in the differential diagnosis of a patient with dyspnea awaiting a heart transplant. ( Bacal, F; Bocchi, EA; Demarchi, LM; Drager, LF; Fajardo, GM; Pires, PV; Silva, CP; Souza, GE, 2006) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop long after amiodarone withdrawal." | 5.17 | Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal. ( Hachiya, H; Hirao, K; Isobe, M; Kawabata, M; Nakamura, T; Sasano, T; Sugiyama, K; Tanaka, Y; Yagishita, A, 2013) |
| "Amiodarone-induced thyrotoxicosis (AIT) should be included in differential diagnoses of thyrotoxicosis in presence of a suggestive drug history." | 3.76 | [A rare cause of thyreotoxicosis]. ( Fend, F; Kurth, R; Müssig, K; Sauer-Schulz, A; Schnauder, G; Teichmann, R, 2010) |
| "A 70-year-old woman suffering from atrial fibrillation was treated with amiodarone, but developed acute respiratory failure necessitating mechanical ventilation for four weeks." | 3.69 | [Respiratory insufficiency due to pulmonary toxicity of amiodarone]. ( Jukema, GJ; Kerkhof, SC; Strack van Schijndel, RJ; ter Maaten, JC, 1995) |
| "A case of amiodarone pulmonary toxicity (APT) occurring within days of the start of therapy and presenting with hemoptysis is reported." | 3.69 | Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. ( Goldstein, I; Heller, I; Isakov, A; Segev, D; Topilsky, M, 1997) |
| "Amiodarone was used to treat cardiac arrhythmias that had been refractory to conventional medical therapy." | 3.66 | Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. ( Gorham, JP; Graham, EL; Greene, HL; Gross, BW; Kudenchuk, PJ; Sears, GK; Trobaugh, GB; Werner, JA, 1983) |
| " Although the pathologic findings of amiodarone lung can be distinctive, the histologic demonstration of foam cells and ultrastructural lamellar inclusions alone does not distinguish toxic from nontoxic patients receiving amiodarone." | 2.38 | Clinical aspects of amiodarone pulmonary toxicity. ( Kennedy, JI, 1990) |
| "Amiodarone is a class III antiarrhythmic medication used extensively to treat ventricular arrhythmias." | 1.33 | The importance of amiodarone pulmonary toxicity in the differential diagnosis of a patient with dyspnea awaiting a heart transplant. ( Bacal, F; Bocchi, EA; Demarchi, LM; Drager, LF; Fajardo, GM; Pires, PV; Silva, CP; Souza, GE, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 6 (20.69) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 13 (44.83) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Papanikolaou, IC | 1 |
| Makou, I | 1 |
| Markatis, E | 1 |
| Voruganti, DC | 1 |
| Cadaret, L | 1 |
| Rambarat, CA | 1 |
| Winchester, DE | 1 |
| Slostad, BD | 1 |
| Prasad, M | 1 |
| Anavekar, NS | 1 |
| Haddad, FG | 1 |
| Mulrooney, S | 1 |
| Lussi, C | 1 |
| Christ, M | 1 |
| Flömer, F | 1 |
| Said, SM | 1 |
| Hahn, J | 1 |
| Alexander, S | 1 |
| Braun-Dullaeus, RC | 1 |
| Esperer, HD | 1 |
| Yagishita, A | 1 |
| Hachiya, H | 1 |
| Kawabata, M | 1 |
| Nakamura, T | 1 |
| Sugiyama, K | 1 |
| Tanaka, Y | 1 |
| Sasano, T | 1 |
| Isobe, M | 1 |
| Hirao, K | 1 |
| Scheschkowski, T | 1 |
| Budweiser, S | 1 |
| Stiefelhagen, P | 1 |
| Sauer-Schulz, A | 1 |
| Müssig, K | 1 |
| Kurth, R | 1 |
| Fend, F | 1 |
| Teichmann, R | 1 |
| Schnauder, G | 1 |
| Hsieh, YC | 1 |
| Huang, JL | 1 |
| Chin, CS | 1 |
| Lin, TC | 1 |
| Liao, YC | 1 |
| Ting, CT | 1 |
| Wu, TJ | 1 |
| Michalski, T | 1 |
| Blasco, LM | 1 |
| Duello, KM | 1 |
| Louh, IK | 1 |
| Burger, CD | 1 |
| Malhotra, A | 1 |
| Muse, VV | 1 |
| Mark, EJ | 1 |
| Silva, CP | 1 |
| Bacal, F | 1 |
| Pires, PV | 1 |
| Drager, LF | 1 |
| Souza, GE | 1 |
| Fajardo, GM | 1 |
| Demarchi, LM | 1 |
| Bocchi, EA | 1 |
| Minhaj, MM | 1 |
| Zvara, DA | 1 |
| Nayyar, P | 1 |
| Maslow, A | 1 |
| Greene, HL | 1 |
| Graham, EL | 1 |
| Werner, JA | 1 |
| Sears, GK | 1 |
| Gross, BW | 1 |
| Gorham, JP | 1 |
| Kudenchuk, PJ | 1 |
| Trobaugh, GB | 1 |
| ter Maaten, JC | 1 |
| Strack van Schijndel, RJ | 1 |
| Jukema, GJ | 1 |
| Kerkhof, SC | 1 |
| Ansoborlo, P | 1 |
| Constans, J | 1 |
| Le Métayer, P | 1 |
| Conri, C | 1 |
| Goldstein, I | 1 |
| Topilsky, M | 1 |
| Segev, D | 1 |
| Isakov, A | 1 |
| Heller, I | 1 |
| Verswijvel, G | 1 |
| Franssens, Y | 1 |
| Deraemaeker, L | 1 |
| Leyssens, G | 1 |
| Govaerts, E | 1 |
| Theunissen, P | 1 |
| Rabe, J | 1 |
| Kulinna, W | 1 |
| Lehmann, KJ | 1 |
| Georgi, M | 1 |
| Kagawa, FT | 1 |
| Kirsch, CM | 1 |
| Jensen, WA | 1 |
| Wehner, JH | 1 |
| Hiranniramol, S | 1 |
| Braman, S | 1 |
| O'Brien, A | 1 |
| Kennedy, JI | 1 |
| Dorian, P | 1 |
| Cazzadori, A | 1 |
| Braggio, P | 1 |
| Barbieri, E | 1 |
| Ganassini, A | 1 |
1 review available for amiodarone and Dyspnea
| Article | Year |
|---|---|
Clinical aspects of amiodarone pulmonary toxicity.
Topics: Amiodarone; Bronchoalveolar Lavage Fluid; Dyspnea; Humans; Lung Diseases; Prognosis | 1990 |
1 trial available for amiodarone and Dyspnea
| Article | Year |
|---|---|
Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; | 2013 |
27 other studies available for amiodarone and Dyspnea
| Article | Year |
|---|---|
Amiodarone and diffuse alveolar hemorrhage.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cough; Dyspnea; Female; Hemorrhage; Humans; Lung Diseases; | 2020 |
Amiodarone-induced interstitial pneumonitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Dyspnea; Humans; Lung Diseases, Inters | 2017 |
Learning from errors: unnecessary intensive care unit admissions.
Topics: Administration, Intravenous; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; | 2017 |
Shortness of breath, fever, cough, and more in an elderly woman.
Topics: Aged, 80 and over; Amiodarone; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Influ | 2018 |
A Shiny Liver!
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical and Drug Induce | 2019 |
Crazy Paving Pattern.
Topics: Aged, 80 and over; Amiodarone; Anti-Bacterial Agents; Atrial Fibrillation; Dyspnea; Female; Glucocor | 2018 |
Exercise intolerance in patients on dronedarone. What is the underlying mechanism?
Topics: Amiodarone; Arrhythmias, Cardiac; Dronedarone; Dyspnea; Exercise Tolerance; Female; Humans; Male; Mi | 2013 |
[In Process Citation].
Topics: Aged; Amiodarone; Bronchoscopy; Dyspnea; Humans; Lung Diseases, Interstitial; Macrophages, Alveolar; | 2016 |
[A hypertensive patient with atrial fibrillation has increasing dyspnea. Cardiac or pulmonary etiology?].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dyspnea; Electric Countershock; Femal | 2009 |
[A rare cause of thyreotoxicosis].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Dyspnea; Glucoco | 2010 |
Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantab | 2011 |
[79-year-old patient with dyspnoea and blue skin colour].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Cyanosis; Dermatitis, Photoallergic; Dia | 2011 |
Trepopnea due to amiodarone-induced diffuse alveolar hemorrhage.
Topics: Acenocoumarol; Aged; Amiodarone; Anemia; Anti-Arrhythmia Agents; Anticoagulants; Dyspnea; Hemoptysis | 2013 |
48-Year-old woman with dyspnea, cough, and weight loss.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cough; Diagnosis, Differential; Drug-Relate | 2012 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2003. An 82-year-old man with dyspnea and pulmonary abnormalities.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Bundle | 2003 |
The importance of amiodarone pulmonary toxicity in the differential diagnosis of a patient with dyspnea awaiting a heart transplant.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Dyspnea; Heart Failure; Heart Tr | 2006 |
Case 1-2007 morbidly obese patient undergoing cardiac surgery.
Topics: Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterizatio | 2007 |
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Digitalis Glycosides; Drug Interact | 1983 |
[Respiratory insufficiency due to pulmonary toxicity of amiodarone].
Topics: Aged; Amiodarone; Atrial Fibrillation; Dyspnea; Female; Humans; Pulmonary Fibrosis; Respiratory Insu | 1995 |
[Pneumopathy caused by amiodarone in internal medicine: 8 cases].
Topics: Aged; Aged, 80 and over; Amiodarone; Dyspnea; Female; Humans; Lung Diseases, Interstitial; Male; Ret | 1993 |
Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cough; Dyspnea; Fever; | 1997 |
Amiodarone induced pulmonary toxicity.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aspartate Aminotr | 1998 |
[Dyspnea and thoracic pain. A patient with recurring ventricular arrhythmia].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chest Pain; Dose-Response Relationsh | 1999 |
A 77-year-old man with bilateral pulmonary infiltrates and shortness of breath.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Dyspnea; Fatal Outcome; Heart Failure; Humans; Lung Diseas | 2000 |
Cracking a dyspnea mystery. Drug-induced pulmonary fibrosis.
Topics: Aged; Amiodarone; Dyspnea; Humans; Male; Pulmonary Fibrosis | 2001 |
Syncope, tachycardia, and exertional dyspnea.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Coronary Disease; Dyspnea; Elect | 1985 |
Amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Benzofurans; Cough; Dyspnea; Female; Humans; Middle Aged; Pulmonary Fibrosis; Respirator | 1986 |